Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacira BioSciences, Inc. - Common Stock (NQ:PCRX)

25.45 -0.45 (-1.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pacira BioSciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 225 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
Via Benzinga
4 Analysts Have This to Say About Pacira BioSciences
Via Benzinga
Analyst Ratings for Pacira BioSciences
Via Benzinga
Looking Into Pacira BioSciences's Return On Capital Employed
Via Benzinga
Why Pacira BioSciences Shares Are Trading Lower Today
Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the  
Via Benzinga
Recap: Pacira BioSciences Q1 Earnings
Via Benzinga
What 6 Analyst Ratings Have To Say About Pacira BioSciences
Via Benzinga
Analyst Expectations for Pacira BioSciences's Future
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 12 stocks hit new 52-week lows. 
Via Benzinga
Pacira BioSciences's Return On Capital Employed Insights
Via Benzinga
Pacira Touts Positive Data From EXPAREL Study In Toe Correction Surgery
Via Benzinga
Pacira Posts Topline Data From Knee Surgery Study With Its Flagship Pain Management Drug
Via Benzinga
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Earnings Preview For Pacira BioSciences
Via Benzinga
Where Pacira BioSciences Stands With Analysts
Via Benzinga
Pacira BioSciences' Return On Capital Employed Overview
  
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 16 companies set new 52-week lows. 
Via Benzinga
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 49 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 70 companies set new 52-week lows. 
Via Benzinga
Pacira BioSciences: Q3 Earnings Insights
Pacira BioSciences (NASDAQ:PCRX) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Pacira Pharmaceuticals Stock Shows Rising Relative Strength
On Friday, Pacira Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 69 to 73. 
Via Investor's Business Daily
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
Via Benzinga
Pacira BioSciences: Q2 Earnings Insights
  Pacira BioSciences (NASDAQ:PCRX) reported its Q2 earnings results on Wednesday, August 3, 2022. Here's what investors need to know about the announcement. 
Via Benzinga
Needham Maintains Buy Rating for Pacira BioSciences: Here's What You Need To Know
Needham has decided to maintain its Buy rating of Pacira BioSciences (NASDAQ:PCRX) and lower its price target from $84.00 to $76.00. Shares of Pacira BioSciences are trading up 3.85% over the last 24... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Jefferies raised Tapestry, Inc. (NYSE: TPR) price target from $30 to $45. Tapestry shares rose 2.2% to close at $31.60 on Tuesday. 
Via Benzinga
Pacira Pharmaceuticals Stock Shows Improved Relative Price Performance; Still Shy Of Benchmark
On Wednesday, Pacira Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 66 to 75. 
Via Investor's Business Daily
Regeneron Pharmaceutical Stock Sees RS Rating Jump To 82
Looking for the best stocks to buy? Focus on those with rising relative price strength, such as Regeneron Pharmaceutical stock. 
Via Investor's Business Daily
Vertex Pharmaceuticals Receives Composite Rating Upgrade
The IBD SmartSelect Composite Rating for VRTX stock increased from 94 to 96 Tuesday, a sign of strong fundamentals. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.